Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika Vacchelli

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Oncoimmunology|May 6, 2015
Trial watch: IDO inhibitors in cancer therapyErika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
Oncoimmunology|November 29, 2013
Trial watch: Dendritic cell-based interventions for cancer therapyErika Vacchelli, Ilio Vitale, Alexander Eggermont, et al.
Cell Cycle (Georgetown, Tex.)|October 17, 2012
Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteinsFederico Pietrocola, Guillermo Mariño, Delphine Lissa, et al.
Oncoimmunology|December 25, 2012
Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effectsOliver Kepp, Laurie Menger, Erika Vacchelli, et al.
Cell Cycle (Georgetown, Tex.)|April 29, 2014
Coffee induces autophagy in vivoFederico Pietrocola, Shoaib Ahmad Malik, Guillermo Mariño, et al.
Oncoimmunology|July 23, 2014
Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity SetAbdul Qader Sukkurwala, Sandy Adjemian, Laura Senovilla, et al.
Oncoimmunology|July 23, 2014
Trial Watch: Adoptive cell transfer for anticancer immunotherapyFernando Aranda, Erika Vacchelli, Florine Obrist, et al.
Oncoimmunology|May 8, 2015
Trial watch: Tumor-targeting monoclonal antibodies for oncological indicationsErika Vacchelli, Jonathan Pol, Norma Bloy, et al.
Oncoimmunology|August 2, 2014
Trial Watch: Toll-like receptor agonists in oncological indicationsFernando Aranda, Erika Vacchelli, Florine Obrist, et al.
Autophagy|February 25, 2012
Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell deathIsabelle Martins, Mickaël Michaud, Abdul Qader Sukkurwala, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Oncoimmunology|May 6, 2015
Trial watch: IDO inhibitors in cancer therapyErika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
Oncoimmunology|November 29, 2013
Trial watch: Dendritic cell-based interventions for cancer therapyErika Vacchelli, Ilio Vitale, Alexander Eggermont, et al.
Cell Cycle (Georgetown, Tex.)|October 17, 2012
Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteinsFederico Pietrocola, Guillermo Mariño, Delphine Lissa, et al.
Oncoimmunology|December 25, 2012
Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effectsOliver Kepp, Laurie Menger, Erika Vacchelli, et al.
Cell Cycle (Georgetown, Tex.)|April 29, 2014
Coffee induces autophagy in vivoFederico Pietrocola, Shoaib Ahmad Malik, Guillermo Mariño, et al.
Oncoimmunology|July 23, 2014
Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity SetAbdul Qader Sukkurwala, Sandy Adjemian, Laura Senovilla, et al.
Oncoimmunology|July 23, 2014
Trial Watch: Adoptive cell transfer for anticancer immunotherapyFernando Aranda, Erika Vacchelli, Florine Obrist, et al.
Oncoimmunology|May 8, 2015
Trial watch: Tumor-targeting monoclonal antibodies for oncological indicationsErika Vacchelli, Jonathan Pol, Norma Bloy, et al.
Oncoimmunology|August 2, 2014
Trial Watch: Toll-like receptor agonists in oncological indicationsFernando Aranda, Erika Vacchelli, Florine Obrist, et al.
Autophagy|February 25, 2012
Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell deathIsabelle Martins, Mickaël Michaud, Abdul Qader Sukkurwala, et al.
Pageof 9